[1]Shi A, Zhu G, Wu H, et al. Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced nonsmall cell lung cancer treated with concurrent chemotherapy and intensitymodulated radiotherapy\[J\]. Radiat Oncol, 2010, 5:35.
[2]Wang D, Shi J, Liang S, et al. Dosevolume histogram parameters for predicting radiation pneumonitis using receiver operating characteristic curve\[J\]. Clin Transl Oncol, 2013, 15(5): 364-369.
[3]Yom S, Liao Z, Liu H, et al. Initial evaluation of treatmentrelated pneumonitis in advancedstage nonsmallcell lung cancer patients treated with concurrent chemotherapy and intensitymodulated radiotherapy \[J\]. Int J Radia Oncol Biol Phys, 2007, 68(1): 94-102.
[4]Chen J, Hong J, Zou X, et al. Association between absolute volumes of lung spared from lowdose irradiation and radiationinduced lung injury after intensitymodulated radiotherapy in lung cancer: a retrospective analysis\[J\]. J Radiat Res, 2015, 56(6): 883-888.
[5]Jiang ZQ, Yang K, Komaki R, et al. Longterm clinical outcome of intensitymodulated radiotherapy for inoperable nonsmall cell lung cancer: the MD Anderson experience\[J\]. Int J Radiat Oncol Biol Phys, 2012, 83(1): 332-339.
[6]Tajima G, Delisle AJ, Hoang K, et al. Immune system phenotyping of radiation and radiation combined injury in outbred mice\[J\]. Radiat Res, 2013, 179(1): 101-112.
[7]Ding NH, LI J, Sun LQ. Molecular mechanisms and treatment of radiationinduced lung fibrosis\[J\]. Curr Drug Targets, 2013, 14(11): 1347-1356.
[8]Kotsianidis I, Nakou E, Bouchliou I, et al. Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis\[J\]. Am J Respir Crit Care Med, 2009, 179(12): 1121-1130.
[9]Galati D, De Martino M, Trotta A, et al. Peripheral depletion of NK cells and imbalance of the Treg/Th17 axis in idiopathic pulmonary fibrosis patients\[J\]. Cytokine, 2014, 66(2): 119-126.
[10]Rappl G, Pabst S, Riemann D, et al. Regulatory T cells with reduced repressor capacities are extensively amplified in pulmonary sarcoid lesions and sustain granuloma formation\[J\]. Clin Immunol, 2011, 140(1): 71-83.
[11]Wu P, Miura Y, Hyodoh F, et al. Reduced function of CD4+25+ regulatory T cell fraction in silicosis patients\[J\]. Int J Immunopathol Pharmacol, 2006, 19(2): 357-368.
[12]Liu F, Liu J, Weng D, et al. CD4+CD25+Foxp3+ regulatory T cells depletion may attenuate the development of silicainduced lung fibrosis in mice\[J\]. PLoS One, 2010, 5(11): e15404.
[13]Dong Z, Tai W, Yang Y, et al. The role of alltrans retinoic acid in bleomycininduced pulmonary fibrosis in mice\[J\]. Exp Lung Res, 2012, 38(2): 82-89.
[14]Xiong S, Pan X, Xu L, et al. Regulatory T cells promote βcateninmediated epitheliumtomesenchyme transition during radiationinduced pulmonary fibrosis\[J\]. Int J Radiat Oncol Biol Phys, 2015, 93(2): 425-435.
[15]张纬建,许建华,张洁旻,等.甘草次酸对小鼠急性放射性肺损伤的防治作用\[J\].中国临床药理学与治疗学,2015,2006:629-633.
[16]Xiong S, Guo R, Yang Z, et al. Treg depletion attenuates irradiationinduced pulmonary fibrosis by reducing fibrocyte accumulation, inducing Th17 response, and shifting IFNγ, IL12/IL4, IL5 balance\[J\]. Immunobiology, 2015, 220(11): 1284-1291.
[17]Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells\[J\]. Nat Immunol, 2003, 4(4): 330-336.
[18]Moore MW, Herzog EL. Regulatory T cells in idiopathic pulmonary fibrosis: too much of a good thing?\[J\]. Am J Pathol, 2016, 186(8): 1978-1981.
[19]Lo Re S, Lecocq M, Uwambayinema F, et al. Plateletderived growth factorproducing CD4+ Foxp3+ regulatory T lymphocytes promote lung fibrosis\[J\]. Am J Respir Crit Care Med, 2011, 184(11): 1270-1281.
[20]Peng X, Moore MW, Peng H, et al. CD4+CD25+FoxP3+ regulatory Tregs inhibit fibrocyte recruitment and fibrosis via suppression of FGF9 production in the TGFβ1 exposed murine lung\[J\]. Front Pharmacol, 2014, 5:80.
[21]Bian LQ, Mao L, Bi Y, et al. Loss of regulatory characteristics in CD4(+) CD25(+/hi) T cells induced by impaired transforming growth factor β secretion in pneumoconiosis\[J\]. APMIS, 2017, 125(12): 1108-1116.
[22]Birjandi SZ, Palchevskiy V, Xue Y, et al. CD4(+)CD25(hi)Foxp3(+) cells exacerbate bleomycininduced pulmonary fibrosis\[J\]. Am J Pathol, 2016, 186(8): 2008-2020.
[23]王在强,傅恩清.调节性T细胞在肺纤维化中作用的研究进展\[J\].中华肺部疾病杂志(电子版),2019,1202:237-240.
[24]BovedaRuiz D, D′alessandroGabazza CN, Toda M, et al. Differential role of regulatory T cells in early and late stages of pulmonary fibrosis\[J\]. Immunobiology, 2013, 218(2): 245-254.